Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06600100Not ApplicableRecruiting

Inhibitory Control Training for Excess Weight: Behavioural, Cognitive and Anthropometric Changes

Role: lead

NCT06649994Not ApplicableRecruiting

Transcranial Magnetic Stimulation and Inhibitory Control Training to Reduce Binge Eating: Brain and Behavioral Changes

Role: lead

NCT06668077Not ApplicableRecruiting

Inhibitory Control Training and iTBS for Excess Weight: Behavioral and Brain Changes (InhibE).

Role: lead

NCT05158075Not ApplicableCompleted

Program for the Comprehensive Neurocognitive Treatment of Excess Weight

Role: lead

All 4 trials loaded